Stroke, Vol 23, 3-8, Copyright © 1992 by American Heart Association
BACKGROUND AND PURPOSE: A randomized, double-blind, multicenter clinical
trial of placebo versus nimodipine was conducted to test the hypothesis
that nimodipine would reduce the frequency of death and of worsening by 30%
compared with placebo. METHODS: Nimodipine was used in doses of 60 mg, 120
mg, and 240 mg daily in 1,064 patients treated for 21 days. Treatment was
begun within 48 hours of stroke due to infarction as inferred by initial
computed tomographic scan findings. The Toronto and motor scales were
analyzed by analysis of covariance, using covariance-adjusted means, the
last-value-carried-forward, to compare the baseline value with the 3
assessment days (days 4, 10, and 21). RESULTS: No difference in mortality
or neurological outcome was found with any of the rating scales for the
overall cohort. Planned but post hoc subgroup analysis showed a reduction
in worsening frequency of 30% compared with placebo and significantly
better outcome scores with 120 mg nimodipine daily started within 18 hours
of stroke as measured by the Toronto scale (p less than 0.005) and when the
pretreatment computed tomographic scan was negative (p less than 0.003).
CONCLUSIONS: Nimodipine had no overall effect when treatment was begun
within 48 hours. Confirmation of the benefits suggested by post hoc
analyses for the subgroup treated with 120 mg nimodipine within 18 hours,
and who had negative computed tomographic scans, would require a separate
trial.
ARTICLES
Clinical trial of nimodipine in acute ischemic stroke. The American Nimodipine Study Group [published erratum appears in Stroke 1992 Apr;23(4):615]
This article has been cited by other articles:
 |
|
 |
|
  H. P. Adams Jr, G. del Zoppo, M. J. Alberts, D. L. Bhatt, L. Brass, A. Furlan, R. L. Grubb, R. T. Higashida, E. C. Jauch, C. Kidwell, et al. Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation, May 22, 2007; 115(20): e478 - e534. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. P. Adams Jr, G. del Zoppo, M. J. Alberts, D. L. Bhatt, L. Brass, A. Furlan, R. L. Grubb, R. T. Higashida, E. C. Jauch, C. Kidwell, et al. Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists Stroke, May 1, 2007; 38(5): 1655 - 1711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Elkins, T. Khatabi, L. Fung, J. Rootenberg, and S. C. Johnston Recruiting Subjects for Acute Stroke Trials: A Meta-Analysis Stroke, January 1, 2006; 37(1): 123 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Weaver, J. Leonardi-Bee, F. J. Bath-Hextall, and P. M.W. Bath Sample Size Calculations in Acute Stroke Trials: A Systematic Review of Their Reporting, Characteristics, and Relationship With Outcome Stroke, May 1, 2004; 35(5): 1216 - 1224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. P. Adams Jr, R. J. Adams, T. Brott, G. J. del Zoppo, A. Furlan, L. B. Goldstein, R. L. Grubb, R. Higashida, C. Kidwell, T. G. Kwiatkowski, et al. Guidelines for the Early Management of Patients With Ischemic Stroke: A Scientific Statement From the Stroke Council of the American Stroke Association Stroke, April 1, 2003; 34(4): 1056 - 1083. [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Murkin Neurologic Monitoring During Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2002; 6(1): 35 - 38. [Abstract] [PDF]
|
|
|
|
|
|
J. Horn, R.J. de Haan, M. Vermeulen, P.G.M. Luiten, and M. Limburg Nimodipine in Animal Model Experiments of Focal Cerebral Ischemia: A Systematic Review Stroke, October 1, 2001; 32(10): 2433 - 2438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Uchino, D. Billheimer, and S. C. Cramer Entry Criteria and Baseline Characteristics Predict Outcome in Acute Stroke Trials Stroke, April 1, 2001; 32(4): 909 - 916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Horn, R. J. de Haan, M. Vermeulen, and M. Limburg Very Early Nimodipine Use in Stroke (VENUS) : A Randomized, Double-Blind, Placebo-Controlled Trial Stroke, February 1, 2001; 32(2): 461 - 465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Horn and M. Limburg Calcium Antagonists for Ischemic Stroke : A Systematic Review Stroke, February 1, 2001; 32(2): 570 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Marler, B. C. Tilley, M. Lu, T. G. Brott, P. C. Lyden, J. C. Grotta, J. P. Broderick, S. R. Levine, M. P. Frankel, S. H. Horowitz, et al. Early stroke treatment associated with better outcome: The NINDS rt-PA Stroke Study Neurology, December 12, 2000; 55(11): 1649 - 1655. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Ahmed, P. Nasman, and N. G. Wahlgren Effect of Intravenous Nimodipine on Blood Pressure and Outcome After Acute Stroke Stroke, June 1, 2000; 31(6): 1250 - 1255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. W. Duncan, H. S. Jorgensen, and D. T. Wade Outcome Measures in Acute Stroke Trials : A Systematic Review and Some Recommendations to Improve Practice Stroke, June 1, 2000; 31(6): 1429 - 1438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Infeld, S. M. Davis, G. A. Donnan, M. Yasaka, M. Lichtenstein, P. J. Mitchell, and G. J. Fitt Nimodipine and Perfusion Changes After Stroke Stroke, July 1, 1999; 30(7): 1417 - 1423. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Menon, D. K. Pandey, and L. B. Morgenstern Critical factors determining access to acute stroke care Neurology, August 1, 1998; 51(2): 427 - 432. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. A. Cwik, C. C. Hanstock, P. S. Allen, and W. R. Wayne Martin Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy Neurology, January 1, 1998; 50(1): 72 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. W. Petty, R. D. Brown Jr., J. P. Whisnant, J. D. Sicks, W. M. O'Fallon, and D. O. Wiebers Survival and recurrence after first cerebral infarction: A population-based study in Rochester, Minnesota, 1975 through 1989 Neurology, January 1, 1998; 50(1): 208 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Horowitz and S. Tuhrim Stroke mechanisms and clinical presentation in large subcortical infarctions Neurology, December 1, 1997; 49(6): 1538 - 1541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Systems Approach to Immediate Evaluation and Management of Hyperacute Stroke : Experience at Eight Centers and Implications for Community Practice and Patient Care Stroke, August 1, 1997; 28(8): 1530 - 1540. [Abstract] [Full Text]
|
|
|
|
|
|
J. Turkka, K. Suominen, U. Tolonen, K. Sotaniemi, and V. V. Myllyla Selegiline diminishes cardiovascular autonomic responses in Parkinson's disease Neurology, March 1, 1997; 48(3): 662 - 667. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Miyai, A. D. Blau, M. Reding, and B. T. Volpe Patients with Stroke Confined to Basal Ganglia Have Diminished Response to Rehabilitation Efforts Neurology, January 1, 1997; 48(1): 95 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Dorman and P. A.G. Sandercock Considerations in the Design of Clinical Trials of Neuroprotective Therapy in Acute Stroke Stroke, September 1, 1996; 27(9): 1507 - 1515. [Full Text]
|
|
|
|
|
|
T. Moulin, F. Cattin, T. Crepin-Leblond, L. Tatu, D. Chavot, M. Piotin, J. F. Viel, L. Rumbach, and J. F. Bonneville Early CT signs in acute middle cerebral artery infarction: Predictive value for subsequent infarct locations and outcome Neurology, August 1, 1996; 47(2): 366 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. S. Jorgensen, H. Nakayama, J. Reith, H. O. Raaschou, and T. S. Olsen Factors delaying hospital admission in acute stroke: The Copenhagen Stroke Study Neurology, August 1, 1996; 47(2): 383 - 387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. van der Grond, L.M.P. Ramos, B. C. Eikelboom, and W. P.Th.M. Mali Cerebral metabolic differences between the severe and critical hypoperfused brain Neurology, August 1, 1996; 47(2): 399 - 404. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yanaka, P. J. Camarata, S. R. Spellman, D. E. McDonald, and R. C. Heros Optimal Timing of Hemodilution for Brain Protection in a Canine Model of Focal Cerebral Ischemia Stroke, May 1, 1996; 27(5): 906 - 912. [Abstract] [Full Text]
|
|
|
|
 |
|
 The National Institute of Neurological Disorders a Tissue Plasminogen Activator for Acute Ischemic Stroke N. Engl. J. Med., December 14, 1995; 333(24): 1581 - 1588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. You, J.J. McNeil, H.M. O'Malley SRN, S. M. Davis, and G. A. Donnan Risk factors for lacunar infarction syndromes Neurology, August 1, 1995; 45(8): 1483 - 1487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Ginsberg Review : Neuroprotection in Brain Ischemia: An Update (Part II Neuroscientist, May 1, 1995; 1(3): 164 - 175. [Abstract] [PDF]
|
|
|
|
|
|
H. Henon, O. Godefroy, D. Leys, F. Mounier-Vehier, C. Lucas, P. Rondepierre, A. Duhamel, and J. P. Pruvo Early Predictors of Death and Disability After Acute Cerebral Ischemic Event Stroke, March 1, 1995; 26(3): 392 - 398. [Abstract] [Full Text]
|
|
|
|
|
|
S. A. Lipton and P. A. Rosenberg Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders N. Engl. J. Med., March 3, 1994; 330(9): 613 - 622. [Full Text]
|
|